Close
Login to MyACC
ACC Members


Not a Member?

The Association of Corporate Counsel (ACC) is the world's largest organization serving the professional and business interests of attorneys who practice in the legal departments of corporations, associations, nonprofits and other private-sector organizations around the globe.

Join ACC

1410 Results

Resource Listings

Benchmarking and Research Data

2023 Global Data Privacy Law Survey Report (Womble Bond Dickinson)

By Womble Bond Dickinson LLP

Womble Bond Dickinson’s second annual analyzes the fast-evolving global data privacy law landscape and, for the first time, includes over 200 respondents from both the US and UK.

Some topics include the growing use of biometric data and artificial intelligence (AI), differences between operating in the US, the UK, Europe and more.

Articles

China’s New Regulations on Generative AI

By Rhys McWhirter, Frankie Tam, Sam Chen, Kenny Tam, Jamie Leung, Philip Chow, Jeff Tian (Eversheds Sutherland)

This article discusses China's new regulation on generative artificial intelligence. The new regulations are coming into light in the midst of new generative AI tools being introduced by several major Chinese technology providers.

This also marks China as one of the first countries globally that has direct government oversight over this nascent area of technology.

Articles

Federal Circuit: AI Cannot Be a Named ‘Inventor’ Under the Patent Act

By Phillip Wolfe, Baker Hostetler

On Aug. 5, 2022, the US Court of Appeals for the Federal Circuit in Thaler v. Vidal ruled that an artificial intelligence (AI) system cannot be listed as a named inventor on a patent application, affirming the United States Patent and Trademark Office (USPTO) and US District Court for the Eastern District of Virginia rulings. The Federal Circuit concluded that the Patent Act requires an “inventor,” as defined in Section 100(f), to be a “natural person."

Articles

Building Biotech with Brains: Strategies for Maximizing Value of AI-Driven Biotechnology Inventions

By Aashish R. Karkhanis, Jeffrey Simon

The rapid rise of artificial intelligence (AI) and machine learning (ML) in biotechnology products and services is becoming a driver of the personalized medicine and health care sectors. While this integration can require special consideration during development of a patent portfolio, stakeholders across engineering, legal, and executive teams in both established companies and start-ups can leverage it to create valuable intellectual property (IP) assets in the marketplace.

Articles

New EEOC Initiative Targeting AI Technology Used in Hiring Process Presents Increased Risk of Class Litigation

By Nikki Howell, Steven Moore and Heidi Wilbur, Fox Rothschild LLP

The US Equal Employment Opportunity Commission (EEOC) and US Department of Justice (DOJ) have announced plans to monitor employers’ use of artificial intelligence (AI) tools in hiring decisions that may discriminate against applicants with disabilities. On May 12, 2022, both agencies issued guidance outlining areas for concern regarding the use of AI in hiring decisions, which provide some insight into their intentions for litigation.

Articles

How the Music Industry Can Fight Back Against Generative AI

Several generative AI models now provide the ability to simulate your favorite artist’s voice and lyrical tempo to create a track that sounds indistinguishable from the real thing. Several artists have voiced their displeasure for these impersonations and music giants are now pushing streaming services to ban music created by AI models with some success. This article from Seyfarth and Shaw discusses how artists can legally fight back. 

Articles

Software as a Medical Device: Challenges Facing the Industry

By Kyle Y. Faget, Nathan A. Beaver, Jessa Boubker, Thomas B. Ferrante, Rachel B. Goodman, Eric L. Sophir, Nicholas J. Zepnick, Austin J. Kim (Foley & Lardner LLP)

The intersection of software, technology and health care and the proliferation of software as a medical device in the health care arena has become common place and has spurred significant innovations. This article discusses legal and regulatory considerations related to Software as a Medical Device (SaMD).

ACC